iRhythm Technologies (IRTC) financial statements

Healthcare · Medical Devices · Market cap $3.7B

iRhythm Technologies reported revenue of $747M in fiscal 2025, up 31.4% a year over 9 years.

Net income was -$45M and the operating margin -7.7%, against -24.3% in 2016.

Free cash flow was $35M.

The diluted share count rose 505% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.200.20.50.82016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from iRhythm Technologies's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue$64M$99M$147M$215M$265M$323M$411M$493M$592M$747M
Cost of revenue$21M$28M$39M$52M$70M$109M$129M$161M$184M$220M
Gross profit$43M$71M$108M$162M$195M$214M$282M$332M$408M$527M
Research and development$7M$13M$21M$37M$41M$39M$47M$60M$71M$85M
Selling, general and admin$52M$85M$133M$180M$197M$275M$322M$386M$419M$493M
Operating income-$16M-$28M-$46M-$55M-$44M-$100M-$114M-$125M-$116M-$57M
Interest expense$3M$3M$3M$2M$2M$1M$4M$4M$13M$13M
Pre-tax income-$21M-$30M-$50M-$55M-$44M-$101M-$116M-$123M-$113M-$44M
Income tax$0$0$44,000$65,000$229,000$367,000$269,000$750,000$565,000$953,000
Net income-$21M-$30M-$50M-$55M-$44M-$101M-$116M-$123M-$113M-$45M
EPS (diluted)-$3.95-$1.31-$2.11-$2.16-$1.58-$3.46-$3.88-$4.04-$3.63-$1.39
Diluted shares5M23M24M25M28M29M30M31M31M32M
Gross margin67.4%71.5%73.7%75.5%73.5%66.2%68.5%67.3%68.9%70.6%
Operating margin-24.3%-27.8%-31.0%-25.5%-16.5%-31.0%-27.7%-25.4%-19.5%-7.7%
Net margin-32.6%-30.0%-34.2%-25.4%-16.5%-31.4%-28.3%-25.0%-19.1%-6.0%

Balance sheet

Fiscal years, from iRhythm Technologies's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$111M$102M$73M$142M$306M$222M$159M$110M$317M$490M
Receivables$9M$13M$20M$24M$30M$46M$50M$61M$80M$76M
Inventory$1M$2M$2M$4M$5M$10M$15M$14M$14M$22M
Total current assets$119M$120M$104M$173M$378M$306M$289M$231M$646M$703M
Property, plant and equipment$5M$6M$9M$26M$34M$56M$76M$104M$125M$152M
Goodwill$862,000$862,000$862,000$862,000$862,000$862,000$862,000$862,000$862,000$862,000
Total assets$138M$133M$118M$306M$512M$463M$448M$433M$931M$1.0B
Total current liabilities$13M$21M$30M$52M$66M$88M$89M$107M$111M$152M
Long-term debt$32M$32M$35M$33M$21M$10M$35M$35M——
Total liabilities$46M$54M$65M$171M$170M$183M$208M$223M$841M$867M
Shareholders' equity$93M$79M$52M$135M$342M$280M$240M$210M$91M$153M
Net debt-$19M$25M$15M$14M-$56M-$106M-$44M-$1M-$420M-$236M

Cash flow

Fiscal years, from iRhythm Technologies's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$17M-$15M-$29M-$22M-$14M-$38M-$23M-$50M$3M$81M
Capital spending$3M$4M$5M$20M$14M$28M$30M$40M$34M$46M
Free cash flow-$19M-$18M-$34M-$42M-$27M-$66M-$53M-$91M-$31M$35M
Stock-based compensation$2M$10M$16M$26M$42M$55M$58M$77M$76M$88M
Share buybacks (net)——————$0$0-$25M$0
Net borrowing—$0$4M$0-$2M-$12M$14M$0——
Free cash flow margin-30.3%-18.6%-23.3%-19.7%-10.3%-20.4%-12.9%-18.4%-5.2%4.6%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for IRTC.
Open IRTC in Investingly

Questions

What was iRhythm Technologies's revenue in 2025?

$747M in fiscal 2025, from its 10-K filing.

How much free cash flow does iRhythm Technologies generate?

$35M in fiscal 2025 (operating cash flow minus capital spending).

From iRhythm Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.